BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20801881)

  • 1. An exceptionally potent inducer of cytoprotective enzymes: elucidation of the structural features that determine inducer potency and reactivity with Keap1.
    Dinkova-Kostova AT; Talalay P; Sharkey J; Zhang Y; Holtzclaw WD; Wang XJ; David E; Schiavoni KH; Finlayson S; Mierke DF; Honda T
    J Biol Chem; 2010 Oct; 285(44):33747-55. PubMed ID: 20801881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, molecular modeling and NAD(P)H:quinone oxidoreductase 1 inducer activity of novel cyanoenone and enone benzenesulfonamides.
    Ghorab MM; Higgins M; Alsaid MS; Arafa RK; Shahat AA; Dinkova-Kostova AT
    J Enzyme Inhib Med Chem; 2014 Dec; 29(6):840-5. PubMed ID: 24417210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly potent activation of Nrf2 by topical tricyclic bis(cyano enone): implications for protection against UV radiation during thiopurine therapy.
    Kalra S; Knatko EV; Zhang Y; Honda T; Yamamoto M; Dinkova-Kostova AT
    Cancer Prev Res (Phila); 2012 Jul; 5(7):973-81. PubMed ID: 22659146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cytoprotective role of the Keap1-Nrf2 pathway.
    Baird L; Dinkova-Kostova AT
    Arch Toxicol; 2011 Apr; 85(4):241-72. PubMed ID: 21365312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Keap1-Nrf2 system as an in vivo sensor for electrophiles.
    Uruno A; Motohashi H
    Nitric Oxide; 2011 Aug; 25(2):153-60. PubMed ID: 21385624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the multiple sensor mechanism of the Keap1-Nrf2 system.
    Takaya K; Suzuki T; Motohashi H; Onodera K; Satomi S; Kensler TW; Yamamoto M
    Free Radic Biol Med; 2012 Aug; 53(4):817-27. PubMed ID: 22732183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress.
    Dinkova-Kostova AT; Liby KT; Stephenson KK; Holtzclaw WD; Gao X; Suh N; Williams C; Risingsong R; Honda T; Gribble GW; Sporn MB; Talalay P
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4584-9. PubMed ID: 15767573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide Synthase.
    Li W; Zheng S; Higgins M; Morra RP; Mendis AT; Chien CW; Ojima I; Mierke DF; Dinkova-Kostova AT; Honda T
    J Med Chem; 2015 Jun; 58(11):4738-48. PubMed ID: 25965897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keap1 cysteine 288 as a potential target for diallyl trisulfide-induced Nrf2 activation.
    Kim S; Lee HG; Park SA; Kundu JK; Keum YS; Cha YN; Na HK; Surh YJ
    PLoS One; 2014; 9(1):e85984. PubMed ID: 24489685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keap1 degradation by autophagy for the maintenance of redox homeostasis.
    Taguchi K; Fujikawa N; Komatsu M; Ishii T; Unno M; Akaike T; Motohashi H; Yamamoto M
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13561-6. PubMed ID: 22872865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin.
    Liby K; Yore MM; Roebuck BD; Baumgartner KJ; Honda T; Sundararajan C; Yoshizawa H; Gribble GW; Williams CR; Risingsong R; Royce DB; Dinkova-Kostova AT; Stephenson KK; Egner PA; Yates MS; Groopman JD; Kensler TW; Sporn MB
    Cancer Res; 2008 Aug; 68(16):6727-33. PubMed ID: 18701497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizations of Three Major Cysteine Sensors of Keap1 in Stress Response.
    Saito R; Suzuki T; Hiramoto K; Asami S; Naganuma E; Suda H; Iso T; Yamamoto H; Morita M; Baird L; Furusawa Y; Negishi T; Ichinose M; Yamamoto M
    Mol Cell Biol; 2016 Jan; 36(2):271-84. PubMed ID: 26527616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial response and cellular protection through the Keap1/Nrf2 system during the exposure of primary mouse hepatocytes to 1,2-naphthoquinone.
    Miura T; Shinkai Y; Jiang HY; Iwamoto N; Sumi D; Taguchi K; Yamamoto M; Jinno H; Tanaka-Kagawa T; Cho AK; Kumagai Y
    Chem Res Toxicol; 2011 Apr; 24(4):559-67. PubMed ID: 21384861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Nrf2 activation in livers from Keap1-knockdown mice increases expression of cytoprotective genes that detoxify electrophiles more than those that detoxify reactive oxygen species.
    Reisman SA; Yeager RL; Yamamoto M; Klaassen CD
    Toxicol Sci; 2009 Mar; 108(1):35-47. PubMed ID: 19129213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NAD(P)H:quinone oxidoreductase 1 inducer activity of some novel anilinoquinazoline derivatives.
    Ghorab MM; Alsaid MS; Higgins M; Dinkova-Kostova AT; Shahat AA; Elghazawy NH; Arafa RK
    Drug Des Devel Ther; 2016; 10():2515-24. PubMed ID: 27540279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arsenic induces NAD(P)H-quinone oxidoreductase I by disrupting the Nrf2 x Keap1 x Cul3 complex and recruiting Nrf2 x Maf to the antioxidant response element enhancer.
    He X; Chen MG; Lin GX; Ma Q
    J Biol Chem; 2006 Aug; 281(33):23620-31. PubMed ID: 16785233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinone-induced activation of Keap1/Nrf2 signaling by aspirin prodrugs masquerading as nitric oxide.
    Dunlap T; Piyankarage SC; Wijewickrama GT; Abdul-Hay S; Vanni M; Litosh V; Luo J; Thatcher GR
    Chem Res Toxicol; 2012 Dec; 25(12):2725-36. PubMed ID: 23035985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation.
    Blake DJ; Singh A; Kombairaju P; Malhotra D; Mariani TJ; Tuder RM; Gabrielson E; Biswal S
    Am J Respir Cell Mol Biol; 2010 May; 42(5):524-36. PubMed ID: 19520915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of biotin conjugates of (±)-(4bS,8aR,10aS)-10a-ethynyl-4b,8,8-trimethyl-3,7-dioxo-3,4b,7,8,8a,9,10,10a-octahydro-phenanthrene-2,6-dicarbonitrile, an activator of the Keap1/Nrf2/ARE pathway, for the isolation of its protein targets.
    Saito A; Higgins M; Zheng S; Li W; Ojima I; Dinkova-Kostova AT; Honda T
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5540-3. PubMed ID: 24018193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Keap1/Nrf2 protein axis plays a role in osteoclast differentiation by regulating intracellular reactive oxygen species signaling.
    Kanzaki H; Shinohara F; Kajiya M; Kodama T
    J Biol Chem; 2013 Aug; 288(32):23009-20. PubMed ID: 23801334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.